Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 33

Sort by

Sort Order Select

Journal Articles

Myeloma Heterogeneity within Its Complex Immune Ecosystem

Jana Jakubikova, PhD, Danka Cholujova, PhD, Gabor Beke, PhD, Zachary R Hunter, PhD, Teru Hideshima, MD PhD, Merav Leiba, MD, Krzysztof Jamroziak, MD PhD, Paul G. Richardson, MD, Eftathios Kastritis, David M. Dorfman, MD PhD, Kenneth C. Anderson, MD

Blood (2019) 134 (Supplement_1): 4354.

https://doi.org/10.1182/blood-2019-132193

Published: 2019

Journal Articles

High-Dimensional Heterogeneity of Waldenström Macroglobulinemia within Its Immune Tumor Microenvironment

Jana Jakubikova, PhD, Danka Cholujova, PhD, Gabor Beke, PhD, Zachary R Hunter, PhD, Teru Hideshima, MD PhD, Ludmila Flores, Merav Leiba, MD, Paul G. Richardson, MD, Eftathios Kastritis, David M. Dorfman, MD PhD, Steven P Treon, MD PhD FRCP, Kenneth C. Anderson, MD

Blood (2019) 134 (Supplement_1): 3975.

https://doi.org/10.1182/blood-2019-130011

Published: 2019

Journal Articles

STK405759 As a Novel Tubulin Active Agent for Multiple Myeloma Therapy

Gabriela Rozic, PhD, Paukov Lena, MSc, Jana Jakubikova, PhD, Duek Adrian, MD, Abraham Avigdor, MD, Arnon Nagler, MD MSc, Merav Leiba, MD

Blood (2015) 126 (23): 5348.

https://doi.org/10.1182/blood.V126.23.5348.5348

Published: 2015

Journal Articles

Inter and Intra-Clonal Heterogeneity in Multiple Myeloma and Waldenstrom Macroglobulinemia

Jana Jakubikova, PhD, Danka Cholujova, PhD, Teru Hideshima, MD PhD, Jacob P. Laubach, MD, Nikhil C. Munshi, MD, Steven P. Treon, MD PhD, Paul Richardson, MD, Efstathios Kastritis, MD, David M Dorfman, MD PhD, Kenneth C. Anderson, MD PhD

Blood (2014) 124 (21): 2070.

https://doi.org/10.1182/blood.V124.21.2070.2070

Published: 2014

Journal Articles

Evaluation of Immune Profile in Patients with Multiple Myeloma Using Cytof Technology

Jana Jakubikova, PhD, Efstathios Kastritis, MD, Danka Cholujova, PhD, Teru Hideshima, MD PhD, Ludmila M Flores, Merav Leiba, MD, Jacob P. Laubach, MD, Nikhil C. Munshi, MD, Paul Richardson, MD, David M Dorfman, MD PhD, Kenneth C. Anderson, MD PhD

Blood (2014) 124 (21): 3404.

https://doi.org/10.1182/blood.V124.21.3404.3404

Published: 2014

Journal Articles

Mimicking Myeloma Niche Ex Vivo

Jana Jakubikova, PhD, Danka Cholujova, PhD, Richard W Groen, PhD, Jungnam Joo, PhD, Sun-Young Kong, MD PhD, Teru Hideshima, MD PhD, Rikio Suzuki, MDPhD, Jan Sedlak, PhD, Constantine S Mitsiades, MD PhD, David M Dorfman, MD PhD, Jacob P. Laubach, MD, Nikhil C. Munshi, MD, Paul G. Richardson, MD PhD, Kenneth Anderson, MD PhD

Blood (2014) 124 (21): 2076.

https://doi.org/10.1182/blood.V124.21.2076.2076

Published: 2014

Journal Articles

Cell Non-Autonomous Modulation Of Tumor Cell Responses To Pharmacological Inhibition Of The Proteasome

Eugen Dhimolea, PhD, Richard W.J. Groen, PhD, Catriona A. Hayes, MD, Jana Jakubikova, PhD, Bariteau Megan, Jake E. Delmore, Hannah M. Jacobs, Julio-Cesar Marin, Gregory Della Penna, Douglas W. McMillin, PhD, Ana Acuna, Panisinee Lawasut, MD, Nancy Kohl, PhD, Constantine S. Mitsiades, MD, PhD

Blood (2013) 122 (21): 4454.

https://doi.org/10.1182/blood.V122.21.4454.4454

Published: 2013

Journal Articles

Nanoparticle Arsenic Compound Realgar Effectively Targets Myeloma Stem-Like Side Population

Jana Jakubikova, PhD, Teru Hideshima, MD, PhD, Richard W.J. Groen, PhD, Danka Cholujova, PhD, Zdenka Bujnakova, PhD, Jacob P. Laubach, MD, Nikhil C. Munshi, MD, Paul G. Richardson, MD, Constantine S. Mitsiades, MD, PhD, Peter Balaz, PhD, Jan Sedlak, PhD, Kenneth C. Anderson, MD

Blood (2013) 122 (21): 4455.

https://doi.org/10.1182/blood.V122.21.4455.4455

Published: 2013

Journal Articles

Myeloma Patient-Derived Mesenchymal Stem Cells Grown In 3-D Culture Induce Primary Myeloma Cell Proliferation and Resistance To Therapy

Jana Jakubikova, PhD, Richard W.J. Groen, PhD, Teru Hideshima, MD, PhD, Danka Cholujova, PhD, Jan Sedlak, PhD, Constantine S. Mitsiades, MD, PhD, Jacob P. Laubach, MD, Nikhil C. Munshi, MD, Paul G. Richardson, MD, Kenneth C. Anderson, MD

Blood (2013) 122 (21): 1912.

https://doi.org/10.1182/blood.V122.21.1912.1912

Published: 2013

Journal Articles

Co-Expression Of The MUC1 Oncoprotein and CD34 On Primary Myeloma Bone Marrow Cells Identifies a Population With Myeloma Initiating Potential

Blood (2013) 122 (21): 127.

https://doi.org/10.1182/blood.V122.21.127.127

Published: 2013

Journal Articles

Canonical and noncanonical Hedgehog pathway in the pathogenesis of multiple myeloma

Simona Blotta, Jana Jakubikova, Teresa Calimeri, Aldo M. Roccaro, Nicola Amodio, Abdel Kareem Azab, Umberto Foresta, Constantine S. Mitsiades, Marco Rossi, Katia Todoerti, Stefano Molica, Fortunato Morabito, Antonino Neri, Piersandro Tagliaferri, Pierfrancesco Tassone, Kenneth C. Anderson, Nikhil C. Munshi

Blood (2012) 120 (25): 5002–5013.

https://doi.org/10.1182/blood-2011-07-368142

Published: 2012

Journal Articles

Tumor Cell-Dependent Differences in Stroma-Induced Changes to Bortezomib Sensitivity.

Eugen Dhimolea, PhD, Jana Jakubikova, PhD, Richard W.J. Groen, PhD, Jake E. Delmore, Hannah M. Jacobs, Douglas W. McMilllin, Ana Acuña-Villaorduña, MD, Catriona A. Hayes, MD, Panisinee Lawasut, MD, Constantine S. Mitsiades, MD, PhD

Blood (2012) 120 (21): 2468.

https://doi.org/10.1182/blood.V120.21.2468.2468

Published: 2012

Journal Articles

Formation of the Functional Niche in Vitro by Mimicking the Pathophysiological Features of the Bone Marrow Microenvironment in Multiple Myeloma

Jana Jakubikova, PhD, Richard W.J. Groen, PhD, Sophia Adamia, PhD, Teru Hideshima, MD, PhD, Danka Cholujova, PhD, Jacob P. Laubach, MD, Nikhil C. Munshi, MD, Paul G. Richardson, MD, Kenneth C. Anderson, MD

Blood (2012) 120 (21): 1812.

https://doi.org/10.1182/blood.V120.21.1812.1812

Published: 2012

Journal Articles

Genome-Wide Aberrant Splicing in Patients with Acute Myelold Leukemia (AML) Is Associated with Altered Expression of Splicing Factors

Sophia Adamia, PhD, Hervé Avet-Loiseau, MD, PhD, Jana Jakubikova, Suzan Lazo-Kallanian, John Daley, PhD, Laurence Lode, Ph.D, Ilene Galinsky, ANP, Richard M. Stone, MD, James D. Griffin, MD

Blood (2012) 120 (21): 652.

https://doi.org/10.1182/blood.V120.21.652.652

Published: 2012

Journal Articles

Targeting NAD + salvage pathway induces autophagy in multiple myeloma cells via mTORC1 and extracellular signal-regulated kinase (ERK1/2) inhibition

Michele Cea, Antonia Cagnetta, Mariateresa Fulciniti, Yu-Tzu Tai, Teru Hideshima, Dharminder Chauhan, Aldo Roccaro, Antonio Sacco, Teresa Calimeri, Francesca Cottini, Jana Jakubikova, Sun-Young Kong, Franco Patrone, Alessio Nencioni, Marco Gobbi, Paul Richardson, Nikhil Munshi, Kenneth C. Anderson

Blood (2012) 120 (17): 3519–3529.

https://doi.org/10.1182/blood-2012-03-416776

Published: 2012

Includes: Supplemental data

Journal Articles

Blockade of Nuclear Export Protein CRM1 (chromosomal region maintenance 1, XPO1) by a Novel, Potent and Selective CRM1 Inhibitor KPT-185 Induces Significant Antitumor Activity Against Human Multiple Myeloma

Sun-Young Kong, MD, PhD, Yosef Landesman, PhD, Jana Jakubikova, PhD, Michael A. Sellitto, Antonia Cagnetta, MD, Michele Cea, MD, Michelle C. Chen, Francesca Cottini, MD, Douglas W. McMillin, PhD, Chirag Acharya, MD, William Senapedis, PhD, Sharon Shacham, PhD, MBA, Michael Kauffman, MD, PhD, Dilara McCauley, PhD, Jean-Richard Saint-Martin, BS, Nikhil C. Munshi, MD, Paul G. Richardson, MD, Kenneth C. Anderson, MD, Yu-Tzu Tai, PhD

Blood (2011) 118 (21): 2913.

https://doi.org/10.1182/blood.V118.21.2913.2913

Published: 2011

Journal Articles

Targeting NAD + Salvage Pathway Induces Autophagy in Multiple Myeloma Cells

Michele Cea, MD, Antonia Cagnetta, MD, Yu-Tzu Tai, PhD, Mariateresa Fulciniti, PhD, Teru Hideshima, MD, PhD, Dharminder Chauhan, PhD, Sun-Young Kong, MD, PhD, Teresa Calimeri, M.D., Francesca Cottini, MD, Jana Jakubikova, PhD, Alessio Nencioni, Marco Gobbi, MD, Franco Patrone, Kenneth C. Anderson, MD

Blood (2011) 118 (21): 2920.

https://doi.org/10.1182/blood.V118.21.2920.2920

Published: 2011

Journal Articles

Proteomic Characterization of An Isogenic Multiple Myeloma Cell Line Model of Bortezomib Resistance

*Catriona A. Hayes, MD, *Paul Dowling, PhD, Joseph Negri, Michael Henry, Leutz Buon, Jana Jakubikova, PhD, Jake E Delmore, Douglas W. McMillin, PhD, Steffen Klippel, PhD, Hannah M. Jacobs, Niels W.C.J. van de Donk, MD, PhD, Eugen Dhimolea, PhD, Panisinee Lawasut, MD, MSc, Paul G. Richardson, MD, Kenneth C. Anderson, MD, Martin Clynes, PhD, *Peter O Gorman, MD, PhD, *Constantine S. Mitsiades, MD, PhD

Blood (2011) 118 (21): 1820.

https://doi.org/10.1182/blood.V118.21.1820.1820

Published: 2011

Journal Articles

Proteasome Inhibitors Sensitize Myeloma Cells to T Cell-Mediated Killing

Niels W.C.J. van de Donk, MD, PhD, Henk M. Lokhorst, MD, Maarten Emmelot, Tineke Aarts-Riemens, Douglas W. McMillin, PhD, Gullu Gorgun, PhD, Steffen Klippel, PhD, Eugen Dhimolea, PhD, Jana Jakubikova, PhD, Catriona A. Hayes, MD, Panisinee Lawasut, MD, Jake E Delmore, Nikhil C. Munshi, MD, Paul G. Richardson, MD, Kenneth C. Anderson, MD, Constantine S. Mitsiades, MD, PhD, Tuna Mutis, MD PhD

Blood (2011) 118 (21): 1838.

https://doi.org/10.1182/blood.V118.21.1838.1838

Published: 2011

Journal Articles

Lenalidomide targets clonogenic side population in multiple myeloma: pathophysiologic and clinical implications

Jana Jakubikova, Sophia Adamia, Maria Kost-Alimova, Steffen Klippel, David Cervi, John F. Daley, Dana Cholujova, Sun-Young Kong, Merav Leiba, Simona Blotta, Melissa Ooi, Jake Delmore, Jacob Laubach, Paul G. Richardson, Jan Sedlak, Kenneth C. Anderson, Constantine S. Mitsiades

Blood (2011) 117 (17): 4409–4419.

https://doi.org/10.1182/blood-2010-02-267344

Published: 2011

Includes: Supplemental data

NARROW

Myeloma Heterogeneity within Its Complex Immune Ecosystem

High-Dimensional Heterogeneity of Waldenström Macroglobulinemia within Its Immune Tumor Microenvironment

STK405759 As a Novel Tubulin Active Agent for Multiple Myeloma Therapy

Inter and Intra-Clonal Heterogeneity in Multiple Myeloma and Waldenstrom Macroglobulinemia

Evaluation of Immune Profile in Patients with Multiple Myeloma Using Cytof Technology

Mimicking Myeloma Niche Ex Vivo

Cell Non-Autonomous Modulation Of Tumor Cell Responses To Pharmacological Inhibition Of The Proteasome

Nanoparticle Arsenic Compound Realgar Effectively Targets Myeloma Stem-Like Side Population

Myeloma Patient-Derived Mesenchymal Stem Cells Grown In 3-D Culture Induce Primary Myeloma Cell Proliferation and Resistance To Therapy

Co-Expression Of The MUC1 Oncoprotein and CD34 On Primary Myeloma Bone Marrow Cells Identifies a Population With Myeloma Initiating Potential

Canonical and noncanonical Hedgehog pathway in the pathogenesis of multiple myeloma

Tumor Cell-Dependent Differences in Stroma-Induced Changes to Bortezomib Sensitivity.

Formation of the Functional Niche in Vitro by Mimicking the Pathophysiological Features of the Bone Marrow Microenvironment in Multiple Myeloma

Genome-Wide Aberrant Splicing in Patients with Acute Myelold Leukemia (AML) Is Associated with Altered Expression of Splicing Factors

Targeting NAD + salvage pathway induces autophagy in multiple myeloma cells via mTORC1 and extracellular signal-regulated kinase (ERK1/2) inhibition

Blockade of Nuclear Export Protein CRM1 (chromosomal region maintenance 1, XPO1) by a Novel, Potent and Selective CRM1 Inhibitor KPT-185 Induces Significant Antitumor Activity Against Human Multiple Myeloma

Targeting NAD + Salvage Pathway Induces Autophagy in Multiple Myeloma Cells

Proteomic Characterization of An Isogenic Multiple Myeloma Cell Line Model of Bortezomib Resistance

Proteasome Inhibitors Sensitize Myeloma Cells to T Cell-Mediated Killing

Lenalidomide targets clonogenic side population in multiple myeloma: pathophysiologic and clinical implications

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only